Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 12, Number 1, February 2021, pages 16-24


Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)

Figures

Figure 1.
Figure 1. Dynamics of alterations in SP and DP in experimental rats. 1: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks; 2: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks followed by 3 weeks of spontaneous recovery; 3: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks (4 + 3 weeks); 4: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks, from the beginning of the fifth week (weeks 5 - 7), intraperitoneal administration of L-arginine (300 mg/kg) was added. SP: systolic pressure; DP: diastolic pressure; L-NAME: N-nitro-methyl ether-L-arginine.
Figure 2.
Figure 2. Dynamics of alterations of indicators of pulse rate and PP in experimental rats. 1: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks; 2: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks followed by 3 weeks of spontaneous recovery; 3: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks (4 + 3 weeks); 4: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks, from the beginning of the fifth week (weeks 5 - 7), intraperitoneal administration of L-arginine (300 mg/kg) was added. PP: pulse pressure; L-NAME: N-nitro-methyl ether-L-arginine.
Figure 3.
Figure 3. Dynamics of alterations of NO content in the rats’ arterial and venous blood. 1: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks; 2: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 4 weeks followed by 3 weeks of spontaneous recovery; 3: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks (4 + 3 weeks); 4: rats with intraperitoneal administration of L-NAME (40 mg/kg) for 7 weeks, from the beginning of the fifth week (weeks 5 - 7), intraperitoneal administration of L-arginine (300 mg/kg) was added. NO: nitric oxide; L-NAME: N-nitro-methyl ether-L-arginine.
Figure 4.
Figure 4. The overall correlation and its statistical significance between NO and PP levels (combined group including parameters of subgroups I, IIa, IIb and IIc). NO: nitric oxide; PP: pulse pressure.

Tables

Table 1. Morphometric Parameters of Carotid Artery
 
GroupsID (µm)WT (µm)
*P < 0.01 vs. controls. **P < 0.01 vs. L-NAME. ID: inner diameter; WT: wall thickness; L-NAME: N-nitro-methyl ether-L-arginine.
Group I825 ± 25.521.39 ± 0.85
Group IIa832 ± 22.630.21 ± 0.89*
Group IIb829 ± 23.031.54 ± 0.85*
Group IIc828 ± 26.733.53 ± 3.41*
Group III827 ± 24.524.56 ± 2.45**

 

Table 2. Correlation and Its Statistical Significance Between NO and PP Levels Within Groups
 
GroupsrP
NO: nitric oxide; PP: pulse pressure.
Group I (control)-0.680.06
Group IIa-0.720.045
Group IIb-0.70.06
Group IIc-0.730.06
Group III-0.750.05